Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04358237 |
|---|---|
| Brief Title: | Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. (LUPER) |
| First Submitted : | April 3, 2020 |
| First Submitted that Met QC Criteria : | April 20, 2020 |
| First Posted : | April 24, 2020 |
| Last Update Submitted that Met QC Criteria : | February 1, 2024 |
| Last Update Posted : | February 2, 2024 |